Clinical Trial Update: A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED) [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating the safety and tolerability of V260 in healthy Chinese adults, children, and infants for Rotavirus gastroenteritis, with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• V260

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus Gastroenteritis | Phase 1 | Status: COMPLETED | Results posted: 2011-04-15